VRAX
Virax Biolabs Group·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-02-07
Latest data update time: Updated on 2026-02-07
2.44 / 10Overall Score
UnderperformInvestment Rating
2.44 / 10Overall Score
UnderperformInvestment Rating
Should I Buy VRAX Now?
- Based on a composite score of 2.44/10, we rate VRAX as a Underperform. Our analysis breaks down into 1.06/10 for Fundamentals, 1.51/10 for Technicals, and 3.59/10 for Sentiment, indicating the stock is likely to Face downward pressure.
What is the current technical signals for VRAX?
Is VRAX fundamentally strong?
What is the market sentiment for VRAX?
Should I Buy VRAX Now?
- Based on a composite score of 2.44/10, we rate VRAX as a Underperform. Our analysis breaks down into 1.06/10 for Fundamentals, 1.51/10 for Technicals, and 3.59/10 for Sentiment, indicating the stock is likely to Face downward pressure.
Is VRAX fundamentally strong?
What is the current technical signals for VRAX?
What is the market sentiment for VRAX?
